Biosig Technologies, Inc. (NASDAQ:STEX – Get Free Report) CIO Mitchell Young Williams bought 51,511 shares of the stock in a transaction on Friday, January 23rd. The stock was purchased at an average cost of $3.03 per share, with a total value of $156,078.33. Following the purchase, the executive directly owned 1,051,511 shares of the company’s stock, valued at approximately $3,186,078.33. This represents a 5.15% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link.
Biosig Technologies Trading Up 4.6%
STEX opened at $3.40 on Tuesday. Biosig Technologies, Inc. has a twelve month low of $0.40 and a twelve month high of $14.11.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings started coverage on Biosig Technologies in a research note on Friday. They issued a “sell (d-)” rating for the company. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Biosig Technologies presently has a consensus rating of “Sell”.
Biosig Technologies Company Profile
Biosig Technologies (NASDAQ:STEX) is a medical technology company focused on developing advanced signal acquisition and processing solutions for cardiac electrophysiology. The company’s work centers on improving the clarity and interpretability of intracardiac signals captured during electrophysiology procedures, with the goal of helping clinicians identify arrhythmogenic substrates and make more informed procedural decisions.
Its primary offering is a signal-processing platform that combines proprietary hardware and software to amplify, filter and display intracardiac electrical activity with reduced noise and distortion.
Further Reading
- Five stocks we like better than Biosig Technologies
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Biosig Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biosig Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
